Cost of a Mediterranean diet and walking intervention to reduce risk of dementia and improve quality of life in independent living populations in Australia: the MedWalk randomised controlled trial

Date

2025

Authors

Bracci, E.L.
Davis, C.R.
Meyer, D.
Kingsley, M.
Breckon, J.
Minihane, A.M.
Itsiopoulos, C.
Macpherson, H.
Scholey, A.
Davison, K.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

British Journal of Nutrition, online, 2025; online(12):1-10

Statement of Responsibility

Conference Name

Abstract

There is growing evidence that optimising dietary quality and engaging in physical activity (PA) can reduce dementia and cognitive decline risk and improve psychosocial health and quality of life (QoL). Multimodal interventions focusing on diet and PA are recognised as significant strategies to tackle these behavioural risk factors; however, the cost-effectiveness of such interventions is seldom reported. A limited cost consequence based on a 12-month cluster-randomised Mediterranean diet (MedDiet) and walking controlled trial (MedWalk) was undertaken. In addition, QoL data were analysed. Programme costs ($AUD2024) covered staff to deliver the MedWalk programme and foods to support dietary behaviour change. The primary outcome measure of this study was change in QoL utility score, measured using the Assessment of Quality of Life (AQoL-8D). Change scores were compared for the groups using general linear models while controlling for demographic factors associated with baseline group differences and attrition. Change in QoL (decreased, maintained or improved) was determined using a cross-tabulation test. MedWalk programme costs were estimated at $2695 AUD per participant and control group cost at $165 per person - a differential cost of $2530. Mean change in utility scores from baseline to 12 months was not statistically significant between groups. Nevertheless, the MedWalk group was significantly less likely to experience a reduction in their QoL (20<middle dot>3 % MedWalk v. 42<middle dot>6 % control group) (P = 0<middle dot>020). A MedDiet and walking intervention may have a role in preventing decline in QoL of older Australians; however, longer-term follow-up would be beneficial to see if this is maintained.

School/Discipline

Dissertation Note

Provenance

Description

Data source: Supplementary material, https://doi.org/10.1017/S0007114525105333

Access Status

Rights

Copyright 2025 The Author(s). This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence, which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited. (https://creativecommons.org/licenses/by/4.0/)

License

Grant ID

Call number

Persistent link to this record